Skip to main content

Table 2 CML epidemiology in Lithuania in 2000–2013

From: Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013

Epidemiology

Calendar period

2000–2004

2005–2009

2010–2013

2000–2013

Male

Female

All

Male

Female

All

Male

Female

All

Male

Female

All

Incidence rate

 CR

1.72

1.34

1.51

1.37

1.15

1.25

1.17

0.91

1.03

1.44

1.15

1.28

 ASR (W)

1.20

0.87

1.00

1.00

0.72

0.86

0.88

0.65

0.75

1.04

0.76

0.88

Mortality rate

 CR

0.98

0.68

0.82

0.83

0.80

0.82

0.82

0.58

0.69

0.89

0.69

0.78

 ASR (W)

0.62

0.38

0.47

0.61

0.46

0.52

0.52

0.29

0.38

0.59

0.38

0.46

  1. ASR (W) age-standardized (weighted) rate, CR crude rate
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us